Bi-specific Antibody (Traverse Biotech)

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug NameBi-specific Antibody (Traverse Biotech)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsSolid tumoursLymphoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTraverse Biotech Inc

China Registration ClassN/A

Develop Information

Active CompaniesTraverse Biotech Inc

Inactive CompaniesN/A

Active IndicationsSolid tumoursLymphoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A